key: cord-0807198-pqy0w2bj
authors: Freeman, Esther E.; McMahon, Devon E.; Hruza, George J.; Irvine, Alan D.; Spuls, Phyllis I.; Smith, Catherine H.; Mahil, Satveer K.; Castelo-Soccio, Leslie; Cordoro, Kelly M.; Lara-Corrales, Irene; Naik, Haley B.; Alhusayen, Raed; Ingram, John R.; Feldman, Steven R.; Balogh, Esther A.; Kappelman, Michael D.; Wall, Dmitri; Meah, Nekma; Sinclair, Rodney; Beylot-Barry, Marie; Fitzgerald, Matthew; French, Lars E.; Lim, Henry W.; Griffiths, Christopher E.M.; Flohr, Carsten
title: International collaboration and rapid harmonization across dermatologic COVID-19 registries
date: 2020-06-17
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.06.050
sha: a460095ddc61f54322ceb4d8f4f274a3f4486fcf
doc_id: 807198
cord_uid: pqy0w2bj

nan

To the Editor: Across specialties, coronavirus disease-2019 (COVID-19) has ushered in an unprecedented time for international collaboration. As COVID-19 has spread around the world, there has been a movement among dermatologists to better understand the effects of the virus on their patients as well as potential dermatologic manifestations of the disease. During March and April 2020, 8 dermatologic registries focused on COVID-19 were launched worldwide to address these issues (Table I) . 1- 3 We developed a rapid consensus among registry leaders to foster collaboration and data harmonization.

Members from each international registry came together in a virtual consensus meeting in April 2020, facilitated by the American Academy of Dermatology and the International League of Dermatologic Societies. Models of collaboration discussed were (1) linking data across registries for overlapping conditions at the point of data entry and (2) harmonizing data post hoc, using shared variables across registries. As a first step, each dermatologic registry provided a list of the variables they collect across several domains, including registry information, patient demographics, general medical information, prior dermatologic conditions, newonset skin manifestations in the setting of COVID-19, and COVID-19erelated history and outcomes (Supplemental Table I This effort formed the basis for a meta-catalog containing all registry variables so that commonalities and variables in need of harmonization between studies could be easily identified (Supplemental Appendix). As a result of this harmonization process, 2 registries have, for example, changed how they collect demographics to harmonize with other international registries. Additionally, the registries now link to each other to facilitate collaboration at the time of data entry.

Registry leaders also discussed challenges in collaboration, particularly double data entry across different registries. 4 To address this concern, registries added a question at the point of data collection about whether a provider entered a case in another registry and to identify that registry. This additional information will enhance our ability to track double case reporting during analysis, although it is not possible to fully verify deidentified patient data.

An additional limitation is that registries have, thus far, originated from North America, Europe, and Australia. Even though many of these registries are open to global submissions, most are only available in English, which may hinder participation. Active work is needed to include a broader representation of global dermatologists as well as inclusion of patients from all racial/ethnic and socioeconomic groups within each country. 5 Ultimately, the reports generated from these registries will only be as good as the data entered. As physicians and researchers, we must strive to include diversity in these reports so that data collected are representative of the global patient community we look after. Communication and transparency in data sharing, which may take the form of regularly posted aggregate data from the registries as well as periodic update newsletters to dermatology societies internationally, may be a motivator for the dermatology community and may encourage engagement and reporting of cases. Together, we are most powerful when our collective knowledge is used to inform the management and care of our patients affected by COVID-19. 

The AAD COVID-19 Registry: crowdsourcing dermatology in the age of COVID-19

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19

Editorial concernepossible reporting of the same patients with COVID-19 in different reports

Is ethnicity linked to incidence or outcomes of COVID-19?